Botanix Pharmaceuticals Limited

ASX:BOT Stock Report

Market Cap: AU$346.5m

Botanix Pharmaceuticals Management

Management criteria checks 3/4

Botanix Pharmaceuticals' CEO is Howie McKibbon, appointed in Aug 2023, has a tenure of less than a year. total yearly compensation is A$1.06M, comprised of 51.1% salary and 48.9% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth A$880.01K. The average tenure of the management team and the board of directors is 2.3 years and 4.8 years respectively.

Key information

Howie McKibbon

Chief executive officer

AU$1.1m

Total compensation

CEO salary percentage51.1%
CEO tenureless than a year
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Mar 21
Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Sep 06
Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Jan 03
Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Sep 05
Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

May 10
Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

Jan 12
We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

Jul 01
We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Mar 18
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

Jan 24
The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Howie McKibbon's remuneration changed compared to Botanix Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$10m

Sep 30 2023n/an/a

-AU$10m

Jun 30 2023AU$1mAU$542k

-AU$9m

Mar 31 2023n/an/a

-AU$10m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$12m

Jun 30 2022AU$585kAU$126k

-AU$13m

Compensation vs Market: Howie's total compensation ($USD693.67K) is about average for companies of similar size in the Australian market ($USD634.90K).

Compensation vs Earnings: Howie's compensation has increased whilst the company is unprofitable.


CEO

Howie McKibbon

less than a year

Tenure

AU$1,062,005

Compensation

Dr. Howie McKibbon serves as Chief Executive Officer since August 24, 2023 and was its Chief Operating Officer since October 2022 until August 24, 2023. He served as Chief Commercial Officer at Botanix Pha...


Leadership Team

NamePositionTenureCompensationOwnership
Vincent Ippolito
MD & Executive Chairman4.8yrsAU$684.70k0.69%
A$ 2.4m
Howie McKibbon
Chief Executive Officerless than a yearAU$1.06m0.25%
A$ 880.0k
Matthew Callahan
Executive Director4.2yrsAU$572.09k4.74%
A$ 16.4m
Jack Hoblitzell
Senior Vice President of Pharmaceutical Development3.3yrsno datano data
Patricia Walker
Chief Medical Adviser2.3yrsno datano data
Susan Park
Company Secretaryless than a yearno datano data

2.3yrs

Average Tenure

57yo

Average Age

Experienced Management: BOT's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Vincent Ippolito
MD & Executive Chairman4.8yrsAU$684.70k0.69%
A$ 2.4m
Matthew Callahan
Executive Director4.2yrsAU$572.09k4.74%
A$ 16.4m
Stewart Washer
Independent Non-Executive Director5.2yrsAU$128.14k0.14%
A$ 477.4k
Henry Bosch
Non Executive Director7.8yrsAU$315.39k1.2%
A$ 4.1m
Daniel Sharp
Non-Executive Director2.1yrsAU$216.37k0.14%
A$ 468.9k

4.8yrs

Average Tenure

53yo

Average Age

Experienced Board: BOT's board of directors are considered experienced (4.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.